Albertin Jane Tanusantoso, Harmas Yazid Yusuf, Melita Sylvyana



Background: Ameloblastoma is the most common odontogenic tumor. Ameloblastoma is a borderline tumor because it is a benign but locally aggressive tumor with a high recurrence rate if the excision is not complete. The principle of treatment for ameloblastoma is excision all the tumor. This article aimed to conduct a retrospective study to analyze the characteristics of ameloblastoma in patients at Oral and Maxillofacial Surgery Hasan Sadikin Hospital Oral Surgery between the period of January 2018-December 2019
Method: This is a retrospective study with 37 patients diagnosed with ameloblastoma during 2018-2019. We took data from each patient such as gender, age, radiological features, histopathological diagnosis of the location of ameloblastoma, management, defects, reconstruction.
Result: A total of 22 patients were diagnosed with plexiform ameloblastoma, 12 cases of follicular ameloblastoma, 3 cases of mixed plexiform and follicular ameloblastoma. 31 patients were treated radically, while 6 patients were treated conservatively. Radical treatment is more often used to reduce recurrence rates, whereas conservative measures are indicated in children and adolescents, as well as adult patients with unilocular ameloblastoma types.
Conclusion: The most characteristic of ameloblastoma is plexiform ameloblastoma in the mandible. Ameloblastoma is usually performed radically and reconstructed with an AO plate.


Ameloblastoma; Epidemiology; Indonesia

Full Text:



Nalabolu GRK, Mohiddin A, Hiremath SKS, et al. Epidemiological Study of Odontogenic Tumors : An Institutional Experience. Journal of Infection and Public Health.2017; 10 : 324 - 330

Andersson L, Khanberg KE, Pogrel MA. Oral and Maxillofacial Surgery. 2010. ed-1; 32:629-728. United Kingdom : Blackwell Publishing

Fonseca RJ, Carlson ER, Ness GM. Oral and Maxillofacial Surgery. 2018. ed-3 (2) : 301.481. Missouri : Elsevier.

Ruslin, M. Hendra FN. Vojdani A, et al. The Epidemiology, Treatment, and Complication of Ameloblastoma in East Indonesia : 6 years retrospective surgery. Med Oral Patol Oral Cir Bucal. 2018. Jan 1;23 (1):e54-8.

Lumerman HS, Bowe RB. 2012.Atlas of Oral and Maxillofacial Histopathology. ed-2; 2: 21-60.Piladelphia : Walters Kluwer Health.

Aramanadka C, Kamath AT, Kudva A. Recurrent Ameloblastoma: A Surgical Challenge. Hindawi : Case Reports in Dentistry. 2018 : 1-6

Mc Clary AC. West RB. Pollack al. Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol. 2016 : 1-13

Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma : current etiopathological concepts and management. Oral Diseases (2018) 24, 307–316

Masthan KMK, Anitha N, Krupaa J, et al. Ameloblastoma. J Pharm Bioallied Sci. 2015 Apr; 7(Suppl 1): S167–S170

Jeddy N, Jeyapradha T, Ananthalakshmi R, Jeeva S, Saikrishna P, Lakshmipathy P. The molecular and genetic aspects in the pathogenesis and treatment of ameloblastoma. J Dr NTR Univ Health Sci. 2013;2:157–61.

Koong B. 2017. Atlas of Oral and Maxillofacial Radiology. ed-1; 10: 153-178 United Kingdom : John Wiley & Sons Ltd.

Sasaki R, Watanabe Y, Ando T, et al. Two Stage Enucleation and Deflation of a Large Unicystic Ameloblastoma with Mural Invasion in Mandible. Craniomaxillofac Trauma Reconstruction. 2014;7:139–142

Barbosa GL, Oliveira ML, Almeida SM, et al. Computed Tomography Imaging Features of Multicystic Granular Cell Ameloblastoma : A Case Report. Stomatos, Vol. 20, 39, Jul-Dec. 2014

Beena VT, Choudhary K, Heera R, et al. Peripheral Ameloblastoma : A Case Report and Review Literature. Hindawi Publishing Corporation. 2012;1 -4

Neville DW, Damm DD, Allen CM, Chi AC. 2016. Oral and Maxillofacial Pathology. ed-4; 15 : 653-668. Missouri : Elsevier

Sadat S, Ahmed M. “Dredging Method”- A Conservative Surgical Approach for the treatment of Ameloblastoma Jaw. Journal of Bangladesh College of Physicians and Surgeons. Vol 29. No.2. 2011

Au SW, Li KY, Choi WS, et al. Risk factors for recurrence of ameloblastoma : a long-term follow up restrospective study. Int. J. Oral Maxillofac. Surg. 2019; 7 : 1-7

Wright JM, Tekkesin MS. Odontogenic tumors: where are we in 2017. J Istanb Univ Fac Dent 2017;51:10–30.

Chichua N, Pai S, Gigineishvili E, Sharashenidze M. Management of Ameloblastoma : Desirable Treatment Approach. Caucasus Journal of Health Science and Public Health. Vol 1. 2016

Gunawardane S R, Attygalla A M. The Dredging Method: an Alternative Technique for Conservative Management of Ameloblastoma. A Case Report. Sri Lanka Dental Journal 2017; 47(02) 23-27. 2017

Malhiero P., Feio L., Costa H., Unicystic Plexiform Ameloblastoma: Case Report. Revista De Saude Amato Lusitano 2013; 32, p. 54

Santis GD, Cordeiro PG, Chiarini L. 2019. Atlas of Mandibular and Maxillary Reconstruction with The Fibula Flap : A step-by-step approach. ed-1;2 : 3-12. Switzerland : Springer

Saghravanian N, Salehinejad J, Ghazi N, Shirdel M, Razi M. A 40-year retrospective clinicopathological study of ameloblastoma in Iran. Asian Pac J Cancer Prev. 2016;17:619–23

Rusdiana, Rusdiana, et al. "Profile of ameloblastoma from a retrospective study in Jakarta, Indonesia." Journal of Dentistry Indonesia 18.2 (2011): 27-32.

Wright JM, Vered M. Update from the 4th edition of the World Health organization classification of head and neck tumors: odontogenic and maxillofacial bone tumors. Head Neck Pathol 2017;11:68e77.

Tatapudi, Ramesh, et al. "Prevalence of ameloblastoma: A three-year retrospective study." Journal of Indian Academy of Oral Medicine and Radiology 26.2 (2014): 145



  • There are currently no refbacks.

Lisensi Creative Commons
This work is licensed under a Lisensi Creative Commons Atribusi-BerbagiSerupa 4.0 Internasional.
Contact us: ODONTO Dental Journal: Jl. Raya Kaligawe Km.4, PO BOX 1054/SM Semarang, Central Java, Indonesia, 50112. Email: